Home
Sign In
About
Curriculum
Activity Information
Target Audience
Learning Objectives
Technical Requirements
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.
Course materials have been developed for use outside of the United States.
|
 |
|
|
|
|
|
|
Nonresponders to Iron Chelation Therapy
Non-response to chelation therapy can be a result of a variety of factors, each presenting particular management challenges. Join Dr. John B. Porter of the University College London and Dr. Kai-Hsin Lin of National Taiwan University Hospital as they discuss the different measurements used to determine non-response, reasons for non-response, variations in the rates of non-response to different chelators, and how best to improve response rates in patients with sub-optimal iron balance. Case presentations describing the management of two very different non-responders from actual practice provide hands-on examples of how to overcome some of these challenges.
|
|
Faculty
|
|
|
Kai-Hsin Lin, MD
Professor of Paediatrics
National Taiwan
University Hospital
Taipei, Taiwan
|
|
|
|
John B. Porter, MA, MD, FRCP
Professor, Department of
Haematology
University College
London
London, United Kingdom
|
|
|
Target Audience
This activity is designed for haematologists, medical oncologists, haematology-oncology specialists, and other healthcare professionals involved in the screening, evaluation, treatment, and management of adults and children with iron overload, resulting from the spectrum of chronic iron overload diseases.
|
Learning Objectives
After participating in this activity, participants should be better able to:
- Evaluate the reasons for patient non-response to chelation therapy in order to determine how best to improve response rates in patients with sub-optimal iron balance.
|
Disclosure Information
Kai-Hsin Lin, MD, has disclosed no significant relationships.
John B. Porter, MA, MD, FRCP, has received grant/research support from and is on the speakers bureau of Novartis Pharmaceuticals Corporation; and is a consultant for Genzyme Corporation, Resonance Health Ltd, and Novartis Pharmaceuticals Corporation.
|
|
|
|
|
|
|
